{"id":7216,"date":"2013-07-23T18:36:25","date_gmt":"2013-07-23T23:36:25","guid":{"rendered":"http:\/\/medicinainterna.com.mx\/?p=7216"},"modified":"2013-07-23T18:36:25","modified_gmt":"2013-07-23T23:36:25","slug":"criterios-de-inclusion-y-exclusion-en-programa-de-trasplante-cardiaco","status":"publish","type":"post","link":"https:\/\/medicinainterna.com.mx\/?p=7216","title":{"rendered":"Criterios de inclusi\u00f3n y exclusi\u00f3n en programa de trasplante cardiaco."},"content":{"rendered":"<h3><\/h3>\n<table width=\"89%\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td valign=\"top\" width=\"100%\">INCLUSI\u00d3N<br \/>\n1. Consumo m\u00e1ximo de ox\u00edgeno &lt;14 ml\/kg\/min (o 40% del previsto) y limitaci\u00f3n de la actividad diaria<br \/>\n2. Actividad severamente limitada por isquemia no revascularizable<br \/>\n3. Arritmias ventriculares recurrentes refractarias a todas las modalidades terap\u00e9uticas<br \/>\n4. Disbalance h\u00eddrico persistente a pesar de tratamiento m\u00e9dico estandarizado<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\" width=\"100%\">EXCLUSI\u00d3N<br \/>\n1. Fracci\u00f3n de eyecci\u00f3n &lt;20%<br \/>\n2. Clase funcional de la NYHA III- IV<br \/>\n3. Historia de arritmias ventriculares<br \/>\n4. Consumo m\u00e1ximo de ox\u00edgeno &gt;15 ml\/kg\/min<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Fuente: HO&#8217;Connell JB, Gunnar RM, Evans RW, Fricker FJ, Hunt SA, Kirklin JK.. 24th Bethesda Conference. Cardiac transplantation. JACC 1993; 22: 8-14.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>INCLUSI\u00d3N 1. Consumo m\u00e1ximo de ox\u00edgeno &lt;14 ml\/kg\/min (o 40% del previsto) y limitaci\u00f3n de la actividad diaria 2. Actividad severamente limitada por isquemia no revascularizable 3. Arritmias ventriculares recurrentes refractarias a todas las modalidades terap\u00e9uticas 4. Disbalance h\u00eddrico persistente a pesar de tratamiento m\u00e9dico estandarizado EXCLUSI\u00d3N 1. Fracci\u00f3n de eyecci\u00f3n &lt;20% 2. Clase funcional &hellip; <a href=\"https:\/\/medicinainterna.com.mx\/?p=7216\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Criterios de inclusi\u00f3n y exclusi\u00f3n en programa de trasplante cardiaco.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-7216","post","type-post","status-publish","format-standard","hentry","category-cardiologia"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts\/7216","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7216"}],"version-history":[{"count":0,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts\/7216\/revisions"}],"wp:attachment":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7216"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7216"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7216"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}